NCT07053995

Brief Summary

After obtaining an informed consent a detailed history and clinical examination was performed. Labs were carried out to fulfill inclusion and exclusion criteria. Women were randomly divided into two groups. In Intervention group vaginal cleaning was done with 50cc diluted antiseptic solution where as control group had abdominal scrub only. Participants were followed and incision site was checked at day 14.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2021

Completed
3.9 years until next milestone

First Submitted

Initial submission to the registry

June 23, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

July 8, 2025

Completed
Last Updated

July 8, 2025

Status Verified

July 1, 2025

Enrollment Period

6 months

First QC Date

June 23, 2025

Last Update Submit

July 2, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Endometrial Infection

    Body temperature was measured postoperatively along with any dicharge of pain around uterine region 24hrs after surgery

    14 days

  • Surgical site infection

    Incision site was inspected on 4th and 14th post operative day and documented any evidence of infection signs according to Southampton wound grading system.

    14 days

Study Arms (2)

Participants with vaginal cleaning

EXPERIMENTAL

Total of 38 participants included randomly after informed consent. Vaginal cleaning with 50cc (0.5cc chlorhexidine) along with abdominal scrubbing was done before giving incision for C-section. Prophylactic antibiotics were given. Participants were followed and incision site was inspected on day 14. Data was recorded.

Procedure: Vaginal cleaning

Participants with non vaginal cleansing

OTHER

Total of 38 participants included randomly after informed consent. Only routine abdominal scrubbing was done before giving incision for C-section. Prophylactic antibiotics were given. Participants were followed and incision site was inspected on day 14. Data was recorded.

Other: Non vaginal cleansing

Interventions

Before giving incision for C-section surgery, vaginal cleaning was done with 50cc diluted antiseptic solution as a single push.

Participants with vaginal cleaning

Routine abdominal scrubbing was carried out before incision. No vaginal cleaning was done before incision.

Participants with non vaginal cleansing

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Pregnant women between 18-40 years
  • Gestational age greater than 36 weeks undergoing elective C section

You may not qualify if:

  • Pregnant women with history of allergic reactions to chlorhexidine
  • Placenta previa on ultrasound scan
  • Diabetes Mellitus on fasting blood sugar
  • Anemia (Hb less than 7g/dl)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Khyber Teaching Hospital Peshawar Pakistan

Peshawar, Khyber Pakhtunkhwa, 23301, Pakistan

Location

MeSH Terms

Conditions

Infections

Study Officials

  • Dr Hira Hassan, MBBS FCPS

    Khyber Teaching Hospital Peshawar

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant

Study Record Dates

First Submitted

June 23, 2025

First Posted

July 8, 2025

Study Start

February 1, 2021

Primary Completion

July 31, 2021

Study Completion

July 31, 2021

Last Updated

July 8, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations